UroGen Pharma Ltd. announced the appointment of Elizabeth (Liz) Barrett as President and Chief Executive Officer effective immediately. She will also serve on the Company's Board of Directors. Ms. Barrett, who will be based in New York, replaces Ron Bentsur.

Mr. Bentsur will step down from his position at the Company but will continue to serve in an advisory capacity as needed to ensure a smooth transition.